Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Deficiency of Adenosine Deaminase 2 (DADA2) Presenting As Familial Hodgkin Lymphoma

Fahad Alabbas, Omar Alsharief, Isabelle Meyts, Fatma Albatniji, Michael Hershfield, Adnan Mansoor, MD PhD, Ghaleb Elyamany, MD PhD

Blood (2018) 132 (Supplement 1): 5373.

https://doi.org/10.1182/blood-2018-99-116431

Published: 2018

Journal Articles

EBV-Related Post-Transplant Lymphoproliferative Disease in Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience and Considerations Regarding CNS Involvement

Anna Vardi, MD PhD, Ioanna Sakellari, Andriana Lazaridou, Apostolia Papalexandri, Ioannis Batsis, Despina Mallouri, Anastasia Marvaki, Tasoula Touloumenidou, Evangelia Yannaki, Michalis Iskas, Varnavas Constantinou, Eleni Gavriilaki, MD, Styliani Papaemmanouil, Achilles Anagnostopoulos

Blood (2018) 132 (Supplement 1): 5706.

https://doi.org/10.1182/blood-2018-99-118008

Published: 2018

Journal Articles

Comparative Analysis of Serological Markers of Herpes Viruses and Hypergammaglobulinaemia in Patients with Angioimmunoblastic T-Cell Lymphoma

Natalia G. Chernova, MD PhD, Dmitry S. Tikhomirov, PhD, Natalia P. Soboleva, MD, Yulia Sidorova, MD PhD, Marina N. Sinitsyna, MD, Tatiana A. Tupoleva, MD PhD, Valentina N. Dvyrnik, MD PhD, Eugene E. Zvonkov, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5180.

https://doi.org/10.1182/blood.V130.Suppl_1.5180.5180

Published: 2017

Journal Articles

Prolonged Remission Achieved in a Relapsing Idiopathic Multicentric Castleman Disease Patient with a Novel, Targeted Treatment Approach

David C Fajgenbaum, MDMBA,MSc, Dustin Shilling, PhD, Helen L Partridge, BS, Sheila K Pierson, MS, Jason R Ruth, PhD, Christopher Sheild Nabel, MD PhD, Katie Stone, BS, Vandana Chaturvedi, PhD, Michael B. Jordan, MD, Adam D. Cohen, MD, Vera Krymskaya, PhD, Arthur H Rubenstein, MBBCh, Frits van Rhee, MD PhD, Thomas S Uldrick, MDMS

Blood (2017) 130 (Supplement 1): 3593.

https://doi.org/10.1182/blood.V130.Suppl_1.3593.3593

Published: 2017

Journal Articles

Preliminary Results from Accelerate, an International, Web-Based, Natural History Registry of Castleman Disease

David C Fajgenbaum, MDMBA,MSc, Sheila K Pierson, MS, Dustin Shilling, PhD, Cooper Gardner, Amy Y Liu, BS, Jasira Ziglar, BS, Shawnee Bernstein, BS, Sarah Mann, BS, Jeremy Zuckerberg, MD, Martin Lukac, MD PhD MPH, Raj Kuhan Jayanthan, MD, Mary Guilfoyle, MS, Craig Tendler, MD, Jason R Ruth, PhD, Thomas S Uldrick, MDMS, Frits van Rhee, MD PhD

Blood (2017) 130 (Supplement 1): 4647.

https://doi.org/10.1182/blood.V130.Suppl_1.4647.4647

Published: 2017

Journal Articles

Human Immunodeficiency Virus-Negative Castleman's Disease: Clinicopathological and Laboratory Characteristics and Outcomes in Patients Treated in a Single Institution

Nalini Hasija, MD, Liliana Bustamante, MD, Michael V. Jaglal, MD, Lubomir Sokol, MD PhD

Blood (2015) 126 (23): 5027.

https://doi.org/10.1182/blood.V126.23.5027.5027

Published: 2015

Journal Articles

Clinical and Morphological Features of Different Variants Castleman's Disease

Anait L. Melikyan, MD PhD, Elena K. Egorova, MD PhD, Alla M. Kovrigina, MD PhD Prof., Irina N. Subortseva, MD PhD, Elena A. Gilyazitdinova, MD, Eduard G. Gemdzhian, PhD, Valeri Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 5591.

https://doi.org/10.1182/blood.V126.23.5591.5591

Published: 2015

Journal Articles

Analysis of Large Cohort Shows That Caribbean Adult T Cell Leukemia/Lymphoma Is a Chemotherapy Refractory Disease with Very Poor Prognosis That Behaves Distinctly from Japanese Subtypes

Monica I Zell, Amer Assal, MD, Bhavana Konda, MDMPH, Ira Braunschweig, MD, Olga Derman, MD, Noah Kornblum, MD, Ramakrishna Battini, MD, Amit Verma, MD, Murali Janakiram, MD

Blood (2014) 124 (21): 1685.

https://doi.org/10.1182/blood.V124.21.1685.1685

Published: 2014

Journal Articles

HHV-8-Negative, Idiopathic Multicentric Castleman Disease (iMCD): A Description of Clinical Features and Therapeutic Options through a Systematic Literature Review

David C Fajgenbaum, MD MSc, Amy Liu, Jason Ruth, PhD, Chris Nabel, PhD, Brian Finkelman, BS, Razelle Kurzrock, MD, Frits van Rhee, MD PhD, Arthur Rubenstein, MBBCh

Blood (2014) 124 (21): 4861.

https://doi.org/10.1182/blood.V124.21.4861.4861

Published: 2014

Journal Articles

Integrated Genome Sequencing Reveals Frequent Loss of Function Alterations of ARID1A and Other Epigenetic Modifiers in Sezary Syndrome

Mark Kiel, MDPhD, Anagh A Sahasrabuddhe, PhD, Thiru Velusamy, PhD, Fuzon Chung, PhD, Nathanael G. Bailey, MD, Bryan L Betz, PhD, David W Bahler, MD PhD, Roberto N. Miranda, MD, L. Jeffrey Medeiros, MD, Megan S Lim, MD PhD, Kojo S.J. Elenitoba-Johnson, MD

Blood (2014) 124 (21): 706.

https://doi.org/10.1182/blood.V124.21.706.706

Published: 2014

Journal Articles

Identification of Cell-Type-Specific Mutations in Angioimmunoblastic T-Cell Lymphoma

Tran Bich Nguyen, MD, Mamiko Sakata-Yanagimoto, MD PhD, Yukitsugu Asabe, Kenichi Yoshida, MD PhD, Hideharu Muto, MD PhD, Rie Nakamoto-Matsubara, MD, Koji Izutsu, Naoya Nakamura, MDPhD, Kengo Takeuchi, MD PhD, Seishi Ogawa, MD PhD, Shigeru Chiba, MD PhD

Blood (2014) 124 (21): 3025.

https://doi.org/10.1182/blood.V124.21.3025.3025

Published: 2014

Journal Articles

A Novel Diagnostic Method For AITL By Detecting RHOA G17V Hotspot Mutation Using Allele-Specific Real-Time PCR

Blood (2013) 122 (21): 3000.

https://doi.org/10.1182/blood.V122.21.3000.3000

Published: 2013

Journal Articles

Somatic G17V Rhoa Mutation Specifies Angioimmunoblastic T-Cell Lymphoma

Blood (2013) 122 (21): 815.

https://doi.org/10.1182/blood.V122.21.815.815

Published: 2013

Journal Articles

Merkel-Cell Polyomavirus Is Rarely Associated to B-Chronic Lymphocytic Leukemia and Occurs Late in the Natural History of the Disease

Manola Comar, PhD, Antonio Cuneo, MD, Rosa Rinaldi, MD, Iva Maestri, PhD, Elisabetta Melloni, PhD, Olga Soffritti, MD, Paola Secchiero, PhD, Mitja Nabergoj, MD, Giorgio Zauli, MD, Gabriele Pozzato, MD

Blood (2012) 120 (21): 4578.

https://doi.org/10.1182/blood.V120.21.4578.4578

Published: 2012

Journal Articles

New Characteristics of Translocation in Anaplastic Large T-Cell ALK-Positive Lymphoma

Liliya Gorenkova, Sergei Kravchenko, Andrei Misurin, Yulia Vinogradova, Ekaterina Penskaya, Eduard G. Gemdjian, PhD, Valeri G. Savchenko, MD, PhD

Blood (2012) 120 (21): 4419.

https://doi.org/10.1182/blood.V120.21.4419.4419

Published: 2012

Journal Articles

Anayisis of Chromosomal Alterations by Array-Based Comparative Genomic Hybridization in 25 Patients with Sézary Syndrome.

Giorgia Saporiti, MD, Laura Corti, MS, PhD, Francesco Onida, MD, Daniele Fanoni, MS, Luigia Venegoni, MS, Elisabetta Caprini, PhD, Cristina Cristofoletti, PhD, Giandomenico Russo, MD, PhD, Agostino Cortelezzi, MD, Emilio Berti, MD

Blood (2012) 120 (21): 2714.

https://doi.org/10.1182/blood.V120.21.2714.2714

Published: 2012

Journal Articles

A Targeted Mutational Landscape of Angioimmunoblastic T-Cell Lymphoma: Association Between Advanced Age and Mutations in TET2 and DNMT3A

Oliver Weigert, MD, Nadja Kopp, Sudha Bolla, MD, Oreofe Odejide, MD, Dan Toscano, Matthew A Lunning, DO, Julie Teruya-Feldstein, MD, Abner Louissaint, MD, PhD, Scott J. Rodig, MD, PhD, Steven M. Horwitz, MD, David Weinstock, MD

Blood (2012) 120 (21): 299.

https://doi.org/10.1182/blood.V120.21.299.299

Published: 2012

Journal Articles

The Evaluation of Clinical and Molecular Response to High-Dose Chemotherapy Protocol NHL BFM-90 in Adults with Anaplastic Large Cell ALK-Positive Lymphoma

Liliya Gorenkova, Sergey K Kravchenko, MD, Yulia Vinogradova, Ekaterina Ilyushkina, Andrey Misurin, Valeryi G Savchenko

Blood (2011) 118 (21): 1622.

https://doi.org/10.1182/blood.V118.21.1622.1622

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia: Evaluation of Cytogenetic Markers as Prognostic Factors

Jose Carda, Patricia Sousa, Patricia Olim, Emília Magalhães, Luis Rito, Rui Afonso, Braz Luz, Catarina Geraldes, Marilene Vivan, Emília Cortesão, Lénia Jorge, Isabel Sousa, Adriana Teixeira

Blood (2010) 116 (21): 4860.

https://doi.org/10.1182/blood.V116.21.4860.4860

Published: 2010

Journal Articles

Rituximab, Endoxan, Ganciclovir, Dexamethasone, Tocilizumab Sequential Treatment In Kaposi's Sarcoma-Associated Herpesvirus (KSHV) -Related Multicentric Castleman Disease. A Case Report with 8 Months Follow-up

Francesco Iuliano, Tecla Mingrone, Stefania Infusino, Alessia Perricelli, Angelo Pomillo, Maria Luci, Massimo Di Maio

Blood (2010) 116 (21): 4872.

https://doi.org/10.1182/blood.V116.21.4872.4872

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Deficiency of Adenosine Deaminase 2 (DADA2) Presenting As Familial Hodgkin Lymphoma

EBV-Related Post-Transplant Lymphoproliferative Disease in Allogeneic Hematopoietic Cell Transplantation: Single-Center Experience and Considerations Regarding CNS Involvement

Comparative Analysis of Serological Markers of Herpes Viruses and Hypergammaglobulinaemia in Patients with Angioimmunoblastic T-Cell Lymphoma

Prolonged Remission Achieved in a Relapsing Idiopathic Multicentric Castleman Disease Patient with a Novel, Targeted Treatment Approach

Preliminary Results from Accelerate, an International, Web-Based, Natural History Registry of Castleman Disease

Human Immunodeficiency Virus-Negative Castleman's Disease: Clinicopathological and Laboratory Characteristics and Outcomes in Patients Treated in a Single Institution

Clinical and Morphological Features of Different Variants Castleman's Disease

Analysis of Large Cohort Shows That Caribbean Adult T Cell Leukemia/Lymphoma Is a Chemotherapy Refractory Disease with Very Poor Prognosis That Behaves Distinctly from Japanese Subtypes

HHV-8-Negative, Idiopathic Multicentric Castleman Disease (iMCD): A Description of Clinical Features and Therapeutic Options through a Systematic Literature Review

Integrated Genome Sequencing Reveals Frequent Loss of Function Alterations of ARID1A and Other Epigenetic Modifiers in Sezary Syndrome

Identification of Cell-Type-Specific Mutations in Angioimmunoblastic T-Cell Lymphoma

A Novel Diagnostic Method For AITL By Detecting RHOA G17V Hotspot Mutation Using Allele-Specific Real-Time PCR

Somatic G17V Rhoa Mutation Specifies Angioimmunoblastic T-Cell Lymphoma

Merkel-Cell Polyomavirus Is Rarely Associated to B-Chronic Lymphocytic Leukemia and Occurs Late in the Natural History of the Disease

New Characteristics of Translocation in Anaplastic Large T-Cell ALK-Positive Lymphoma

Anayisis of Chromosomal Alterations by Array-Based Comparative Genomic Hybridization in 25 Patients with Sézary Syndrome.

A Targeted Mutational Landscape of Angioimmunoblastic T-Cell Lymphoma: Association Between Advanced Age and Mutations in TET2 and DNMT3A

The Evaluation of Clinical and Molecular Response to High-Dose Chemotherapy Protocol NHL BFM-90 in Adults with Anaplastic Large Cell ALK-Positive Lymphoma

Chronic Lymphocytic Leukemia: Evaluation of Cytogenetic Markers as Prognostic Factors

Rituximab, Endoxan, Ganciclovir, Dexamethasone, Tocilizumab Sequential Treatment In Kaposi's Sarcoma-Associated Herpesvirus (KSHV) -Related Multicentric Castleman Disease. A Case Report with 8 Months Follow-up

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only